Cargando…
Hypoxia-induced 26S proteasome dysfunction increases immunogenicity of mesenchymal stem cells
Bone marrow-derived allogeneic (donor derived) mesenchymal stem cells (MSCs) are immunoprivileged and are considered to be prominent candidates for regenerative therapy for numerous degenerative diseases. Even though the outcome of initial allogeneic MSCs based clinical trials was encouraging, the o...
Autores principales: | Abu-El-Rub, Ejlal, Sequiera, Glen Lester, Sareen, Niketa, Yan, Weiang, Moudgil, Meenal, Sabbir, Mohammad Golam, Dhingra, Sanjiv |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349874/ https://www.ncbi.nlm.nih.gov/pubmed/30692516 http://dx.doi.org/10.1038/s41419-019-1359-x |
Ejemplares similares
-
Hypoxia-induced shift in the phenotype of proteasome from 26S toward immunoproteasome triggers loss of immunoprivilege of mesenchymal stem cells
por: Abu-El-Rub, Ejlal, et al.
Publicado: (2020) -
Early passaging of mesenchymal stem cells does not instigate significant modifications in their immunological behavior
por: Sareen, Niketa, et al.
Publicado: (2018) -
Graphene Oxide-Gold Nanosheets Containing Chitosan Scaffold Improves Ventricular Contractility and Function After Implantation into Infarcted Heart
por: Saravanan, Sekaran, et al.
Publicado: (2018) -
Comparison of adipose tissue- and bone marrow- derived mesenchymal stem cells for alleviating doxorubicin-induced cardiac dysfunction in diabetic rats
por: Ammar, Hania Ibrahim, et al.
Publicado: (2015) -
Development of iPSC-based clinical trial selection platform for patients with ultrarare diseases
por: Sequiera, Glen Lester, et al.
Publicado: (2022)